The study will compare NHS and social data to track long term impact of childhood blood disorders.
A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...
WASHINGTON — The Food and Drug Administration has approved the first drug treatment for pediatric patients 12 and older with a rare blood disorder. The treatment for acquired thrombotic ...
ScienceAlert on MSN
Scientists Identified a New Blood Group After 50-Year Mystery
A pregnant woman's blood sample taken in 1972 was mysteriously missing a surface molecule found on all other known red blood ...
Newsworthy Women on MSN
One match, one chance: Welsh mom fights rare blood cancer
A single mother in Wales is sharing her story after learning that just one person in the world may hold the key to saving her ...
DAVANAGERE: Even though he himself is a haemophilia patient, it did not deter him from becoming a champion to protect the ...
A single, untargeted proteomics test for rare genetic diseases has been developed. A research team from the University of Melbourne (Australia) and Murdoch Children’s Research Institute (Victoria, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results